CONSUN PHARMA (01681): Lee Cheuk Kwong appointed as Independent Non-executive Director.
Kangzin Pharmaceutical (01681) announced that, effective from February 24, 2025, Ms. Chen Yujun has resigned as an independent...
CONSUN PHARMA (01681) announced that, effective from February 24, 2025: Ms. Chen Yujun has resigned as an independent non-executive director and will no longer serve as chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Li Zhuoguang has been appointed as an independent non-executive director, chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Fang Peicheng will no longer concurrently serve as the Chief Financial Officer; Ms. Chen Yujun has been appointed as the Chief Financial Officer.
Related Articles

Sinolink: The bottom of the real estate market may not be far away. It is expected to stabilize in the first and second quarters of next year.

Tencent (00700) first systematically disclosed R&D progress: AI generates 50% of new code, R&D automation level increases by 67% year-on-year.

China Securities Co., Ltd.: Investment Opportunities in the Commercial Aerospace Industry Chain
Sinolink: The bottom of the real estate market may not be far away. It is expected to stabilize in the first and second quarters of next year.

Tencent (00700) first systematically disclosed R&D progress: AI generates 50% of new code, R&D automation level increases by 67% year-on-year.

China Securities Co., Ltd.: Investment Opportunities in the Commercial Aerospace Industry Chain

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


